TherapeuticsMD, Inc. (TXMD)
Market Closed
1 Sep, 20:00
$
2. 17
-0.01
-0.4587%
After Hours
$
+0.06 +2.765% 2. 23
25.7M Market Cap
- P/E Ratio
- Div Yield
29,908 Volume
- Eps
$ 2.18
Previous Close 
Want to track TXMD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
TherapeuticsMD, Inc. (TXMD) Statistics
Valuation metrics
Market Cap 25.7M
Enterprise value 22.07M
Trailing P/E (ttm) -118.09
Forward P/E 5.69
PEG ratio -0.11
Price/Sales (ttm) 7.86
Price/Book (mrq) 0.95
Enterprise Value/Revenue 6.75
Enterprise Value/EBITDA -5.26
Overview
Shares outstanding 11.57M
Float 9.49M
Shares short 56.77K
% Held by insiders 0.07%
% Held by institutions 0.3%
Average volume (10 days) 22.41K
Average volume (90 days) 70.28K
Price summary
52-Week low 0.99
52-Week high 2.95
Beta 0.56
50-Day moving average 2.09
200-Day moving average 2.15
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 10 Jun 2008
Ex-Dividend Date 6 Jun 2008
Last split factor 1:50
Last split Date 9 May 2022
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -0.07%
Operating margin -1.18%
Operational effectiveness
Return on assets -0.01%
Return on equity -0.01%
Income Statement
Revenue (ttm) 3.35M
Revenue per share (ttm) 0.28
Quarterly revenue growth (yoy) 0.84%
Gross profit (ttm) 3.35M
EBITDA -1.41M
Net income to common (ttm) 86K
Diluted EPS (ttm) -0.02
Quarterly earnings growth (yoy) 0.34%
Balance Sheet
Total cash (mrq) 8.42M
Total cash per share (mrq) 0.79
Total debt (mrq) 4.82M
Total Debt/Equity (mrq) 0.2
Current ratio (mrq) 3.22%
Book value per share (mrq) 2.34
Cash Flow
Cash flow statement 2.67M
Levered free cash flow (LFCF) 1.33M
